Skip to Main Content

Author Details

Robin J Leach
University of Texas Health San Antonio
1984
231
49
PMIDPaper TitleJournal TitlePublished Year
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
36842100Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer.Prostate2023
37788996Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatment.Transl Psychiatry2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37292833Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.medRxiv2023
37311464Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.Am J Hum Genet2023
36626706Targeted Mass Spectrometry Assays for Specific Quantification of Urinary proPSA Isoforms.J Proteome Res2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
34127801Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.Prostate Cancer Prostatic Dis2022
35351104Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.BMC Urol2022
35864460Accommodating heterogeneous missing data patterns for prostate cancer risk prediction.BMC Med Res Methodol2022
34980493Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.Eur Urol2022
35152271Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.Prostate Cancer Prostatic Dis2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
35260348Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer.Clin Genitourin Cancer2022
32930425African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.Int J Cancer2021
33623038Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.Nat Commun2021
34214473Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.Cancer Cell2021
34321211Regulation of telomere homeostasis and genomic stability in cancer by <i>N</i> <sup>6</sup>-adenosine methylation (m<sup>6</sup>A).Sci Adv2021
34162682Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration.Diabetes2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33446094Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling.BMC Microbiol2021
31226226A genome-wide association study of prostate cancer in Latinos.Int J Cancer2020
33615152Human-specific polymorphic pseudogenization of <i>SIGLEC12</i> protects against advanced cancer progression.FASEB Bioadv2020
33319609Lessons Learned from the Medical University of South Carolina Transdisciplinary Collaborative Center (TCC) in Precision Medicine and Minority Men's Health.Am J Mens Health2020
33093161Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review.Cancer Epidemiol Biomarkers Prev2020
32665124A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome.Urol Oncol2020
32614141Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination.Proteomics Clin Appl2020
32409115A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.Eur Urol2020
29422418Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator.Eur Urol Focus2019
31615451Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools.BMC Med Res Methodol2019
30838339Microbiome diversity in carriers of fluoroquinolone resistant <i>Escherichia coli</i>.Investig Clin Urol2019
31139875Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer.Psychopharmacology (Berl)2019
30385837Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study.Prostate Cancer Prostatic Dis2019
29318656Circadian genes and risk of prostate cancer in the prostate cancer prevention trial.Mol Carcinog2018
29887999Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration.J Obes2018
30007819Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer.Eur Urol2018
30300367The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial.PLoS One2018
29778349A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.Eur Urol2018
29464091Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.Oncotarget2018
29117387Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.J Natl Cancer Inst2017
28413904Helicobacter Pylori Infection in Texas Hispanic and Non-Hispanic White Men: Implications for Gastric Cancer Risk Disparities.Am J Mens Health2017
28317149Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.Prostate2017
29254211Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins.Oncotarget2017
26924343Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis.Sci Rep2016
27197965Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.Prostate2016
27556923MBDDiff: an R package designed specifically for processing MBDcap-seq datasets.BMC Genomics2016
27164191Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.Cancer2016
26771888Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.Prostate2016
  • 1 - 50 of 231

Recommended Authors

McGill University and Genome Quebec Innovation Centre
Career Start Year 1998
Number of shared co-authors 5
Division of Clinical Research, Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 5
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Career Start Year 1993
Number of shared co-authors 35
Centre Medical Universitaire
Career Start Year 1992
Number of shared co-authors 1
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 30
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 4
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 3
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 1987
Number of shared co-authors 6
McGill University
Career Start Year 1986
Number of shared co-authors 1
Ontario Institute for Cancer Research
Career Start Year 1986
Number of shared co-authors 16
Center for Precision Health Research, National Human Genome Research Institute
Career Start Year 1986
Number of shared co-authors 7
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Career Start Year 1986
Number of shared co-authors 18
National Institutes of Health
Career Start Year 1983
Number of shared co-authors 5
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 21
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 48
HudsonAlpha Institute for Biotechnology
Career Start Year 1980
Number of shared co-authors 10
National Cancer Institute
Career Start Year 1980
Number of shared co-authors 27
University of California davis
Career Start Year 1978
Number of shared co-authors 14
Norwich Medical School, University of East Anglia
Career Start Year 1978
Number of shared co-authors 33
University of Michigan ann arbor
Career Start Year 1978
Number of shared co-authors 36
New York University Grossman School of Medicine
Career Start Year 1977
Number of shared co-authors 22
Invitae Corporation
Career Start Year 1976
Number of shared co-authors 33
University of Washington
Career Start Year 1975
Number of shared co-authors 6
Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University
Career Start Year 1975
Number of shared co-authors 41
Harvard Medical School
Career Start Year 1973
Number of shared co-authors 4
Johns Hopkins University School of Medicine
Career Start Year 1972
Number of shared co-authors 4
Van Andel Institute
Career Start Year 1972
Number of shared co-authors 46
Rinat (Pfizer Inc.)
Career Start Year 1971
Number of shared co-authors 9
The Ohio State University Comprehensive Cancer Center
Career Start Year 1961
Number of shared co-authors 17

Collaborators

CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 80
University of Texas Health San Antonio
Co-authored papers 50
Eastern Virginia Medical School
Co-authored papers 20
University of Texas Health San Antonio
Co-authored papers 18
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 15
Co-authored papers 14
Co-authored papers 14
Co-authored papers 14
The Institute of Cancer Research
Co-authored papers 13
Co-authored papers 13
University of Southern California
Co-authored papers 13
Fred Hutchinson Cancer Research Center
Co-authored papers 13
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Co-authored papers 12
Co-authored papers 12
University of Texas M.D. Anderson Cancer Center
Co-authored papers 11
Co-authored papers 11
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 11
Co-authored papers 11
Vanderbilt University Medical Center
Co-authored papers 11
The Institute of Cancer Research
Co-authored papers 11
Co-authored papers 10
Stanford University School of Medicine
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 10
National Cancer Institute, National Institutes of Health
Co-authored papers 10
Co-authored papers 9
Co-authored papers 9
Morehouse School of Medicine
Co-authored papers 9
Co-authored papers 9